We handle some incidents by phone, some face to face.
Most of our employees have a known HBsAB status at the time of hire.
Most of our source patients do get tested.
Some employees who are notified that the source has no risks and has negative testing opt out/decline consent of testing for themselves.
We have 4th generation HIV AG/AB testing and generally test 6 weeks, 3 months, 6 months on employees when source testing is positive (some employee opt for a less rigorous schedule when source testing
is negative but the source has potential risks).
Diana Seufert RN, MSN, NP
Boston Medical Center
Occupational & Environmental Medicine
Doctor’s Office Building (DOB) 7th floor, Suite 703
720 Harrison Avenue, Boston, MA 02218
p 617-638-8400 f 617-638-8406
From: MCOH-EH [mailto:mcoh-eh-bounces@mylist.net]
On Behalf Of Wintermeyer, Stephen F.
Sent: Wednesday, February 11, 2015 10:20 AM
To: mcoh-eh@mylist.net
Subject: [MCOH-EH] Needlestick/Blood and body fluid exposure Evaluations
I am reviewing our policy for the management of a needlestick or blood body fluid evaluation.
My understanding is the standard of practice in 2015 is to test a source patient with a Rapid HIV test, HepBsAg and HepCAb tests.
My question for the group is what is the standard of practice of management of the exposed individual. Obviously, counseling about risks and proper needle handling should be performed.
Do you require that the exposed individual come into the Employee Health clinic for face to face counseling or do you handle that by phone?
Do you test the exposed individual for HIV, HepBsAb and HepC for any exposure, or only if there is a specific reason to do so (such as the source patient is HIV +)?
Stephen Wintermeyer, MD, MPH
Director
Associate Professor of Clinical Medicine
Campus Health
Indiana University-Purdue University Indianapolis
Coleman Hall, Suite 100
1140 West Michigan Street
Indianapolis, IN 46202
317-274-8214
